Date: 13.06.19 - 13.06.19

Be inspired and learn from peers and renowned entrepreneurs active in the field of Biopharma. This meeting is for a select group of entrepreneurial scientists, innovators and managers working at universities, start-ups, scale-ups and grown-ups.

13.00   Reception
13.30   Start Program – Keynotes
14.40   Break
15.00   Workshops
17.15   Drinks 

Panorama hall – Chesbrough Building – Pivot Park, Kloosterstraat 9, Oss.

Registration free of charge, number of participants is limited. In case you haven’t received an invitation but would like to visit, please contact us by e-mail


André van de Sande – Advisor to Pivot Park and CEO André van de Sande Consultancy
André is a senior Executive with over 25 years of Life Sciences experience in both mature and emerging markets in Western and Central Europe, Asia Pacific and Middle East Africa. He successfully led organizations ranging from 40 to 1400 employees as CEO, Managing Director and Regional Vice President. Currently André is Chairman of different supervisory boards and advisor to several companies. He recently concluded the second exit of Lifescience Consultancy company Xendo Holding. André holds a MBA degree from Tilburg university, a MSc in Management from Purdue University and followed the supervisory board member program of Nyenrode University.

Key notes

Erik van den Berg – CEO AM-Pharma
Erik has over twenty years experience in the pharmaceutical and biotechnology industries. He joined AM-Pharma in September 2007 as Chief Business Officer and became the company’s CEO in 2011. Previously, as a Senior Executive at Organon he was responsible for leading the Company’s global biotechnology business development. Erik has been involved in the execution of over 20 transactions and partnerships and raised more than €200M in equity and debt financing for biotechnology companies. He is also the founder and board member of two high-tech start-up companies. Erik has a MSc in Chemistry from the University of Utrecht and an MBA from Manchester Business School.

Sander van Asbeck – CEO & founder of Mercurna
Sander is a biomedical scientist with a focus on poly-nucleotides and nano-particle drugs. Based on this experience, he co-founded Mercurna in early 2017 to develop mRNA-based drugs. Over the past 2 years, he has guided Mercurna through an exciting start-up period. In this time, he has been involved in both the management and the day-to-day science to develop Mercurna’s proprietary drug delivery platform. Sander holds a Msc in Biomedical Sciences from the Radboud University Nijmegen and aims to finish his PhD on mRNA-based drugs in the next year.

Workshops (3 x 45 minutes)

Strategy – Sabine Swinkels – Rethinker at the Rethinking Group
Strategy is about being different. Every company has competitors. if you don’t have them yet, you will. That’s the nature of business. You will not beat them if you have the same strategy.  So we need to Zig when they Zag. Sell the Why and not the What.

Elevator pitch – Robin Vissenaekens – Presentation Expert at the Expert Academy 
Elevator pitch means conveying your message in a brief, clear and compact manner.  Elevator talk is also essential for networking and it is a useful tool for establishing fruitful contacts with potential prospects. Elevator talk opens doors for you. A powerful and impactful elevator pitch will enable you to leave a professional and lasting impression and will improve your chances for success.  In this workshop you will learn how to create your own successful elevator speech, and to convey it to others in a convincing way.

Gap analysis – André van de Sande – Advisor to Pivot Park and CEO André van de Sande Consultancy
Once  a strategic direction has been chosen it is povitol to prepare a thorough gap analysis of the company/department. This way it can be established whether goals can be realized. A good gap analysis can make the difference between failure and success.